期刊文献+

皮肌炎伴发肺间质病变的相关因素分析 被引量:4

Analysise of factors related to the development of interstitial lung disease in patients with dermatomyositis
下载PDF
导出
摘要 目的了解皮肌炎肺间质病变的临床特点,探讨影响皮肌炎伴发肺间质病变(ILD)的危险因素。方法回顾性研究近3年来收治的83例皮肌炎(DM)患者临床资料,采用Logistic回归分析皮肌炎伴发ILD的影响因素。结果皮肌炎患者ILD的发生率为42.2%。筛选出皮肌炎伴发ILD的主要相关因素有Gottron's皮疹、恶性肿瘤、雷诺现象、干咳、关节痛和肌力,其中Gottron's皮疹及恶性肿瘤与ILD呈负相关,雷诺现象、干咳、关节痛和肌力与ILD呈正相关。结论Gottron's皮疹阳性或伴发恶性肿瘤的DM患者ILD的发生率降低,有雷诺现象、干咳、关节痛或肌力较好的DM患者发生ILD的概率较高。 Objective To assess the factors related to the development of interstitial lung disease(ILD) in patients with dermatomyositis(DM).Methods The clinical data of 83 patients with dermatomyositis was collected and analyzed retrospectively.The factors related to the development of ILD were identif ied by Binary Logistic regression analysis.Results The prevalence rate of ILD in the total 83 patients with DM was 42.2%.The factors related to the development of ILD were Gottron's eruption,malignancy,Raynaud phenomenon,cough,arthralgia and muscle power grade.Among these factors,Gottron's eruption and malignancy were negatively correlated with the development of ILD.Raynaud phenomenon,cough,arthralgia and muscle power grade were positively correlated with the development of ILD.Conclusion The patients who presented with Gottron's eruption or malignancy are less likely to develop ILD,and those who showed Raynaud phenomenon,cough,arthralgia or higher muscle rank are more likely to develop ILD.
出处 《实用皮肤病学杂志》 2008年第4期200-203,共4页 Journal of Practical Dermatology
关键词 皮肌炎 肺间质病变 dermatomyositis interstitial lung disease
  • 相关文献

参考文献14

二级参考文献22

  • 1蔡怡华,郑捷.血清肌酶在评价皮肌炎与多肌炎合并肺间质病变中的作用[J].诊断学理论与实践,2004,3(4):260-263. 被引量:12
  • 2王红,丁丛珠,孙凌云.以呼吸衰竭为首发表现的多发性肌炎和皮肌炎的临床分析[J].中华风湿病学杂志,2004,8(9):542-544. 被引量:12
  • 3Marie I,Hatron PY,Hachulla E,et al.Pulmonary involvement in polymyositis and in dermatomyositis.J Rheumatol,1998,25:1336-1343.
  • 4[10]Toshinori Takada,Eiichi Suzuki,Masaaki Nakano. Clinical Features of Polymyositis/Dermatomyositis with Steroid-Resistant Interstitial Lung Disease[J]. Intern Med,1998, 37(8):669-673.
  • 5[2]American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)[J]. Am J Respir Crit Care Med, 2000, 161(2 pt 1):646-664.
  • 6[5]Mills ES, Matthews WH. Interstitial pneumonitis in dermatomyositis[J]. J Am Med Assoc, 1956, 160(17):1467-1470.
  • 7[6]Schnabel A, Reuter M, Biederer J, et al. Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment [J]. Semin Arthritis Rheum, 2003, 32(5):2732-2784.
  • 8[7]Fudman E J, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign [J]. Am J Med, 1986, 80(2):329-332.
  • 9[8]Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis [J]. Arthritis Rheum, 2002, 47(6):614-622.
  • 10[9]Ito M, Kaise S, Suzuki S, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease [J]. Clin Rheumatol, 1999, 18(6):462-467.

共引文献72

同被引文献16

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部